{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.2053","value":"0.441"},{"groupId":"OG001","spread":"0","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"155"},{"groupId":"OG001","value":"155"}],"units":"Participants"}],"title":"Bilirubin, Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.1976","value":"0.361"},{"groupId":"OG001","spread":"0.1629","value":"-0.077"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"143"},{"groupId":"OG001","value":"143"}],"units":"Participants"}],"title":"Bilirubin, Visit 12E - Day 90"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.2383","value":"0.431"},{"groupId":"OG001","spread":"0.1863","value":"-0.004"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"134"},{"groupId":"OG001","value":"134"}],"units":"Participants"}],"title":"Bilirubin, Visit 16E - EOYDay 180"}],"denoms":[{"counts":[{"groupId":"OG000","value":"155"},{"groupId":"OG001","value":"155"}],"units":"Participants"}],"description":"Total bilirubin in SOV2012-F1 treated subjects were assessed during the treatment period, measurement units of mg/dL","dispersionType":"Standard Deviation","groups":[{"description":"Patients treated with SOV2012-F1, starting daily dose in MRS-TU-2019EXT is 400 mg - (200 mg with morning meal and 200 mg with evening meal). Dosing is titrated up to a maximum of 800 mg SOV2012-F1 per day (400 mg in the morning with morning meal and 400 mg in the evening with evening meal) or down to a minimum of 100 mg SOV2012-F1 per day (100 mg with morning meal) based on plasma T after 14 and 42 days of treatment. Patients could be titrated to final daily dose levels of 100 mg, 200 mg (100 mg twice daily), 400 mg (200 mg twice daily), 600 mg (300 mg twice daily) or 800 mg (400 mg twice daily). All doses taken with meals.\n\nSOV2012-F1: oral preparation of testosterone undecanoate (TU) in 100 mg, 150 mg and 200 mg strengths.","id":"OG000","title":"SOV2012-F1-treated, Observed"},{"description":"Patients treated with SOV2012-F1, starting daily dose in MRS-TU-2019EXT is 400 mg - (200 mg with morning meal and 200 mg with evening meal). Dosing is titrated up to a maximum of 800 mg SOV2012-F1 per day (400 mg in the morning with morning meal and 400 mg in the evening with evening meal) or down to a minimum of 100 mg SOV2012-F1 per day (100 mg with morning meal) based on plasma T after 14 and 42 days of treatment. Patients could be titrated to final daily dose levels of 100 mg, 200 mg (100 mg twice daily), 400 mg (200 mg twice daily), 600 mg (300 mg twice daily) or 800 mg (400 mg twice daily). All doses taken with meals.\n\nSOV2012-F1: oral preparation of testosterone undecanoate (TU) in 100 mg, 150 mg and 200 mg strengths.","id":"OG001","title":"SOV2012-F1-treated, Change From Baseline"}],"paramType":"MEAN","populationDescription":"Extension Treated Set","reportingStatus":"POSTED","timeFrame":"90 and 180 days","title":"Observed and Change From Baseline in Hematology Parameters in Liver Function Tests","type":"OTHER_PRE_SPECIFIED","unitOfMeasure":"mg/dL"}